Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Reardon

Showing results (21-30 of 404) with videos related to

Pageof 41
Sort By:
Nature Reviews. Neurology|January 20, 2016
Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatmentPatrick Y Wen, David A Reardon
Cancer|June 22, 2016
Adult brainstem gliomasSylvia C Eisele, David A Reardon
Nature Reviews. Clinical Oncology|January 7, 2015
Glioma in 2014: unravelling tumour heterogeneity-implications for therapyDavid A Reardon, Patrick Y Wen
The Lancet. Oncology|July 17, 2010
Is there really a yin and yang to VEGF-targeted therapies?Lee M Ellis, David A Reardon
Nature|March 20, 2009
Cancer: The nuances of therapyLee M Ellis, David A Reardon
Nature Reviews. Clinical Oncology|April 9, 2014
Targeted therapies: Further delineating bevacizumab's response spectrumDavid A Reardon, Patrick Y Wen
Clinical Interventions in Aging|March 5, 2014
Treatment options and outcomes for glioblastoma in the elderly patientNils D Arvold, David A Reardon
Seminars in Immunopathology|February 1, 2017
The development of dendritic cell vaccine-based immunotherapies for glioblastomaDavid A Reardon, Duane A Mitchell
JAMA Oncology|October 8, 2020
Appropriate Analysis of Duration of Response Data in Cancer Trials-ReplyMichael Weller, Kay Tatsuoka, David A Reardon
Neuroimage|May 22, 2007
A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MRElizabeth Bullitt, David A Reardon, J Keith Smith
Pageof 41

Showing results (21-30 of 404) with videos related to

Sort By:
Pageof 41
Nature Reviews. Neurology|January 20, 2016
Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatmentPatrick Y Wen, David A Reardon
Cancer|June 22, 2016
Adult brainstem gliomasSylvia C Eisele, David A Reardon
Nature Reviews. Clinical Oncology|January 7, 2015
Glioma in 2014: unravelling tumour heterogeneity-implications for therapyDavid A Reardon, Patrick Y Wen
The Lancet. Oncology|July 17, 2010
Is there really a yin and yang to VEGF-targeted therapies?Lee M Ellis, David A Reardon
Nature|March 20, 2009
Cancer: The nuances of therapyLee M Ellis, David A Reardon
Nature Reviews. Clinical Oncology|April 9, 2014
Targeted therapies: Further delineating bevacizumab's response spectrumDavid A Reardon, Patrick Y Wen
Clinical Interventions in Aging|March 5, 2014
Treatment options and outcomes for glioblastoma in the elderly patientNils D Arvold, David A Reardon
Seminars in Immunopathology|February 1, 2017
The development of dendritic cell vaccine-based immunotherapies for glioblastomaDavid A Reardon, Duane A Mitchell
JAMA Oncology|October 8, 2020
Appropriate Analysis of Duration of Response Data in Cancer Trials-ReplyMichael Weller, Kay Tatsuoka, David A Reardon
Neuroimage|May 22, 2007
A review of micro- and macrovascular analyses in the assessment of tumor-associated vasculature as visualized by MRElizabeth Bullitt, David A Reardon, J Keith Smith
Pageof 41